SABS, SABSW · CIK 0001833214 · operating
SAB Biotherapeutics, Inc. (SABSW) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. The stock currently trades at $0.03, up 0.00% today, with a 52-week range of $0.04–$0.04. The company trades at a trailing P/E of 0.1x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-3.68 | $-3.68 | +51.8% | |
| 2023 | $-7.64 | $-7.64 | -1676.7% | |
| 2022 | — | $-0.43 | +31.7% | |
| 2021 | $-0.63 | $-0.63 | — | |
| 2020 | — | — | — |